Viewing Study NCT05086627


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2025-12-26 @ 4:16 AM
Study NCT ID: NCT05086627
Status: COMPLETED
Last Update Posted: 2024-08-22
First Post: 2021-09-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer
Sponsor: Hebei Medical University Fourth Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Rectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Locally advanced rectal cancer View
None Neoadjuvant radiotherapy View
None Immune checkpoint inhibitors View
None Programmed death-1 inhibitor View